Jesus Castilla

Has grant

Instituto de Salud Pública de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

CIBER Epidemiología y Salud Pública

Open Date:

Close Date:

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Marcela Guevara

Instituto de Salud Pública de Navarra

SPAIN

View details

Luise Goerlitz

Robert Koch Institute

GERMANY

View details

Pere Godoy

SPAIN

View details

Itziar Casado

Instituto de Salud Pública de Navarra

SPAIN

View details

Iván Martínez-Baz

Profesor asociado

Universidad de Navarra

SPAIN

View details

Noelia Vera Punzano

Instituto de Salud Pública de Navarra

SPAIN

View details

Patricia Soares

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesus Castilla

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study

The Vaccine Training Barometer: Assessing healthcare providers’ confidence to answer vaccine-related questions and their training needs

Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021–2022: A Population-Based Observational Study

Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023

Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey

Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal

Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

COVID-19 infections, hospitalizations, and mortality in Navarre (Spain) between February 2020 and September 2022

Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I-MOVE primary care multicentre study

Meningococcal Group B Vaccine (4CMenB) in Children. Reply

Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study

Collaborators (7)

Marcela Guevara

Luise Goerlitz

Pere Godoy

Itziar Casado

Iván Martínez-Baz

Noelia Vera Punzano

Patricia Soares

Make your next move.

Jesus Castilla

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study

The Vaccine Training Barometer: Assessing healthcare providers’ confidence to answer vaccine-related questions and their training needs

Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021–2022: A Population-Based Observational Study

Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.

Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023

Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey

Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal

Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

COVID-19 infections, hospitalizations, and mortality in Navarre (Spain) between February 2020 and September 2022

Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I-MOVE primary care multicentre study

Meningococcal Group B Vaccine (4CMenB) in Children. Reply

Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study

Collaborators (7)

Marcela Guevara

Luise Goerlitz

Pere Godoy

Itziar Casado

Iván Martínez-Baz

Noelia Vera Punzano

Patricia Soares

Make your next move.

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.